• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Thailand·Healthcare·SKR.BK
Share

Sikarin Public Company Limited Stocks

THB 8Last Updated 27.07.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

THB 476.79M

THB 8
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Decent dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Sikarin Public Company Limited, along with its subsidiaries, functions as a healthcare provider managing hospitals throughout Thailand. The company delivers a comprehensive range of medical services and facilities, encompassing specialized care units for diabetes, endocrine disorders, general medicine, orthopedics, emergency and trauma, various surgical procedures, pediatric care, dentistry, aesthetic treatments, women's health, and fertility. Furthermore, it houses dedicated centers for gastroenterology, neurology, stroke, EENT (Ear, Nose, and Throat), and an international medical center. Diagnostic and therapeutic capabilities are robust, featuring a full laboratory department, diagnostic radiology, CT scan and MRI units, multiple operating rooms, a hemodialysis unit, a physical therapy department staffed with rehabilitation specialists, and a catheter laboratory. Patient accommodation includes intensive care units (ICUs), a coronary care unit (CCU), delivery rooms, nurseries, and a variety of inpatient wards such as general, international, obstetrics and gynecology, after heart and thoracic surgery, medical, and pediatric wards. Beyond its core healthcare operations, Sikarin also oversees the management of rental properties and is involved in the sale of food and beverages. The company's hospital portfolio includes Sikarin Hospital in Bangkok, equipped with 355 beds; Rattarin Hospital in Muang, offering 100 beds; and Sikarin Hat-Yai Hospital in Hat Yai, providing 350 beds. Established in 1979, Sikarin Public Company Limited is headquartered in Bangkok, Thailand.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of fair value

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

29.07.2026 20:35

Noble is first on Wall St. to cover Beasley Broadcast Group, seeing almost 50% upside

29.07.2026 19:56

"The Focus Is Back on Iran": U.S. Stocks See a Sell-Off Ahead of the Fed's Decision

29.07.2026 19:38

"I've been through hell": July could be the worst month in history for Korean stocks

29.07.2026 19:23

Nuclear Resilience: Which Companies Made the List of the World's Most Valuable Mining Companies?

29.07.2026 18:09

Oil prices soared 7% after Trump's remarks about a U.S. retaliatory strike against Iran

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026